Response Biomedical (RPBIF) 1.0800 $RPBIF
Response Biomedical Corp. Announces Management Changes
Marketwire - Tue Sep 16, 4:01PM CDT
Response Biomedical Corp. ("Response" or "the Company"
(TSX: RBM)(OTCBB: RPBIF) announced today a series of management changes. Jeffrey Purvin has resigned from the Board of Directors and as the President and Chief Executive Officer of the Company effective immediately. He will be succeeded as CEO by interim CEO Dr. Anthony "Tony" Holler, M.D., a long time Response Board member. In addition, Dr. Barbara Kinnaird, PhD., has been promoted from Vice President to Chief Operating Officer.
Response Biomedical Corp. Announces New Chairman of the Board
Marketwire - Thu Aug 28, 6:54PM CDT
Response Biomedical Corp. ("Response" or "the Company" (TSX: RBM)(OTCBB: RPBIF) is pleased to announce that Lewis J. "Lew" Shuster has been appointed Chairman of its board of directors (the "Board" . Dr. Peter A. Thompson, the outgoing Chairman, will remain on the Board.
Response Biomedical Corp. Announces Second Quarter 2014 Financial Results
Marketwire - Mon Aug 11, 4:01PM CDT
Response Biomedical Corp. ("Response" or "the Company" (TSX: RBM)(OTCBB: RPBIF) today reported financial results for the second quarter and six months ended June 30, 2014 including a 12% increase in sales and improving gross margin.
Response Biomedical Corp. Schedules Second Quarter 2014 Earnings Release and Conference Call
Marketwire - Tue Aug 05, 12:21PM CDT
Response Biomedical Corp. ("Response" (TSX: RBM) (OTCBB: RPBIF) will release its second quarter 2014 financial results after the markets close on Monday, August 11, 2014.
Response Biomedical Corp. Announces Fourth Quarter and Fiscal 2013 Financial Results
Marketwire - Thu Mar 13, 4:02PM CDT
Response Biomedical Corp. ("Response" or "the Company" (TSX: RBM)(OTCBB: RPBIF) today reported financial results for the fourth quarter and year ended December 31, 2013 including improved margins and reduced operating costs on revenues that were minimally lower than 2012.
Response Biomedical Corp. Schedules Fourth Quarter and Fiscal Year 2013 Earnings Release and Conference Call
Marketwire - Thu Mar 06, 2:45PM CST
Response Biomedical Corp. ("Response" (TSX: RBM) (OTCBB: RPBIF) will release its fourth quarter and fiscal year 2013 financial results after the markets close on Thursday, March 13, 2014.
Response Biomedical Corp. Secures US$2.5 Million Term Loan
Marketwire - Tue Feb 11, 8:03PM CST
Response Biomedical Corp. (TSX: RBM)(OTCBB: RPBIF) ("Response" or the "Company" today announced that it has secured a US$2.5 million term loan from Silicon Valley Bank ("SVB" . The Company will initially draw down US$1.5 million of the facility, and a further US$1.0 million will become available for draw down if certain financial targets are met on or before July 31, 2014. The Company plans to use the funds from the loan to support working capital needs for growing its markets both in the U.S. and internationally, and for general corporate purposes.
Response Biomedical Corp. Announces 2013 Second Quarter Financial Results
Marketwire - Tue Aug 13, 4:01PM CDT
Response Biomedical Corp. ("Response" (TSX: RBM)(OTCBB: RPBIF) today reported financial results for the quarter and six months ended June 30, 2013.
Response Biomedical Corp. Schedules Second Quarter 2013 Earnings Release and Announces Conference Call
Marketwire - Wed Aug 07, 5:39PM CDT
Response Biomedical Corp. ("Response" (TSX: RBM)(OTCBB: RPBIF) will release its second quarter 2013 financial results after the markets close on August 13, 2013.
Response Biomedical Corp. Announces Voting Results
Marketwire - Wed Jun 19, 5:45PM CDT
Response Biomedical Corp. (TSX: RBM) (OTCBB: RPBIF) (the "Company" , in accordance with the requirements of the Toronto Stock Exchange, is pleased to announce the results of voting at its 2013 Annual General and Special Meeting of Shareholders held on June 18, 2013.
Response Biomedical Corp. Announces Management Changes
Marketwire - Tue Sep 16, 4:01PM CDT
Response Biomedical Corp. ("Response" or "the Company"
(TSX: RBM)(OTCBB: RPBIF) announced today a series of management changes. Jeffrey Purvin has resigned from the Board of Directors and as the President and Chief Executive Officer of the Company effective immediately. He will be succeeded as CEO by interim CEO Dr. Anthony "Tony" Holler, M.D., a long time Response Board member. In addition, Dr. Barbara Kinnaird, PhD., has been promoted from Vice President to Chief Operating Officer. Response Biomedical Corp. Announces New Chairman of the Board
Marketwire - Thu Aug 28, 6:54PM CDT
Response Biomedical Corp. ("Response" or "the Company"
(TSX: RBM)(OTCBB: RPBIF) is pleased to announce that Lewis J. "Lew" Shuster has been appointed Chairman of its board of directors (the "Board" . Dr. Peter A. Thompson, the outgoing Chairman, will remain on the Board. Response Biomedical Corp. Announces Second Quarter 2014 Financial Results
Marketwire - Mon Aug 11, 4:01PM CDT
Response Biomedical Corp. ("Response" or "the Company"
(TSX: RBM)(OTCBB: RPBIF) today reported financial results for the second quarter and six months ended June 30, 2014 including a 12% increase in sales and improving gross margin. Response Biomedical Corp. Schedules Second Quarter 2014 Earnings Release and Conference Call
Marketwire - Tue Aug 05, 12:21PM CDT
Response Biomedical Corp. ("Response"
(TSX: RBM) (OTCBB: RPBIF) will release its second quarter 2014 financial results after the markets close on Monday, August 11, 2014. Response Biomedical Corp. Announces Fourth Quarter and Fiscal 2013 Financial Results
Marketwire - Thu Mar 13, 4:02PM CDT
Response Biomedical Corp. ("Response" or "the Company"
(TSX: RBM)(OTCBB: RPBIF) today reported financial results for the fourth quarter and year ended December 31, 2013 including improved margins and reduced operating costs on revenues that were minimally lower than 2012. Response Biomedical Corp. Schedules Fourth Quarter and Fiscal Year 2013 Earnings Release and Conference Call
Marketwire - Thu Mar 06, 2:45PM CST
Response Biomedical Corp. ("Response"
(TSX: RBM) (OTCBB: RPBIF) will release its fourth quarter and fiscal year 2013 financial results after the markets close on Thursday, March 13, 2014. Response Biomedical Corp. Secures US$2.5 Million Term Loan
Marketwire - Tue Feb 11, 8:03PM CST
Response Biomedical Corp. (TSX: RBM)(OTCBB: RPBIF) ("Response" or the "Company"
today announced that it has secured a US$2.5 million term loan from Silicon Valley Bank ("SVB" . The Company will initially draw down US$1.5 million of the facility, and a further US$1.0 million will become available for draw down if certain financial targets are met on or before July 31, 2014. The Company plans to use the funds from the loan to support working capital needs for growing its markets both in the U.S. and internationally, and for general corporate purposes. Response Biomedical Corp. Announces 2013 Second Quarter Financial Results
Marketwire - Tue Aug 13, 4:01PM CDT
Response Biomedical Corp. ("Response"
(TSX: RBM)(OTCBB: RPBIF) today reported financial results for the quarter and six months ended June 30, 2013. Response Biomedical Corp. Schedules Second Quarter 2013 Earnings Release and Announces Conference Call
Marketwire - Wed Aug 07, 5:39PM CDT
Response Biomedical Corp. ("Response"
(TSX: RBM)(OTCBB: RPBIF) will release its second quarter 2013 financial results after the markets close on August 13, 2013. Response Biomedical Corp. Announces Voting Results
Marketwire - Wed Jun 19, 5:45PM CDT
Response Biomedical Corp. (TSX: RBM) (OTCBB: RPBIF) (the "Company"
, in accordance with the requirements of the Toronto Stock Exchange, is pleased to announce the results of voting at its 2013 Annual General and Special Meeting of Shareholders held on June 18, 2013. 
